Losartan, Pembrolizumab and Stereotactic Body Radiation Therapy for the Treatment of Patients With Locally Recurrent, Refractory or Oligometastatic Head and Neck Squamous Cell Carcinoma
University of California, Davis
University of California, Davis
Jules Bordet Institute
Hoosier Cancer Research Network
M.D. Anderson Cancer Center
University Health Network, Toronto
University Health Network, Toronto
Fudan University
University of Chicago
Baptist Health South Florida
Chinese University of Hong Kong
Emory University
Institute of Oncology Ljubljana
Abramson Cancer Center at Penn Medicine
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Umeå University
Memorial Sloan Kettering Cancer Center
Royal North Shore Hospital
H. Lee Moffitt Cancer Center and Research Institute
Mayo Clinic
Fudan University
MemorialCare Health System
Melanoma Institute Australia
British Columbia Cancer Agency
NRG Oncology
City of Hope Medical Center
NYU Langone Health
M.D. Anderson Cancer Center
Centre Francois Baclesse
Thomas Jefferson University
Istituto Clinico Humanitas
Mayo Clinic
University of Michigan Rogel Cancer Center
Sun Yat-sen University
NRG Oncology
NRG Oncology
M.D. Anderson Cancer Center
NRG Oncology
City of Hope Medical Center
Sichuan University
University of Chicago
Mayo Clinic
Tianjin Medical University Cancer Institute and Hospital
The University of Hong Kong
Mayo Clinic
Hoosier Cancer Research Network
Sixth Affiliated Hospital, Sun Yat-sen University
Sichuan University
Weill Medical College of Cornell University
H. Lee Moffitt Cancer Center and Research Institute